Surgery Websites
Willenbring Lab »  Lab Members »  Postdoctoral Fellows »  Emad Heidary Arash, Ph.D.
Emad Heidary Arash, Ph.D.

Emad Heidary Arash, Ph.D.

Postdoctoral Fellow

Contact Information

Open Popup
  • University of Toronto, Toronto, Canada, Ph.D., Biochemistry, 2017
  • University of Tehran, Tehran, Iran, B.S., Cell and Molecular Biology, 2010

Emad Heidary Arash, Ph.D. is a postdoctoral fellow in the Willenbring Lab. He received his Bachelor of Science in Cell and Molecular Biology from the University of Tehran in Iran. Afterwards, he pursued his Ph.D. at the Biochemistry Department of the University of Toronto in the laboratory of Dr. Liliana Attisano where he studied the molecular mechanisms that regulate Hippo pathway. Emad is studying the mechanisms of myofibroblasts to hepatocytes reprogramming.

Data provided by UCSF Profiles, powered by CTSI
  1. MARK4 inhibits Hippo signaling cascade to promote proliferation and migration of breast cancer cells. EMBO reports. 2017; 18(3):420-436. View in PubMed
  2. DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2. Genes and Development. 2016; 30(24):2696-2709. View in PubMed
  3. Arhgef7 promotes the activation of Hippo pathway core kinase Lats. EMBO Journal. 2014; 33(24):2997-3011. View in PubMed
  4. FOXC1 in human trabecular meshwork cells is involved in regulatory pathway that includes miR-204, MEIS2, and ITGß1. Experimental Eye Research. 2013; 111:112-121. View in PubMed
  5. A role for Hipk in the Hippo pathway. Science Signaling. 2013; 6(275):pe18. View in PubMed

 

Site Directory
    X